HomeVenture Capital

Venture Capital

Venture Capital

Medable Secures $304 Million in Funding at $2.1 Billion Valuation; New Round Co-Led by Blackstone Growth, GSR Ventures and Tiger Global

Life Sciences Times - 0
Venture Capital

Egle Therapeutics Raises 40 Million € Series a to Develop First-In-Class T-regulatory Cells Therapies Based On Treg-starvers

Life Sciences Times - 0
Venture Capital

ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million

Life Sciences Times - 0
Venture Capital

ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines

Life Sciences Times - 0
Venture Capital

Marc Schneebaum Joins Avalyn Pharma as Chief Financial Officer

Life Sciences Times - 0
Venture Capital

Carlyle and Leading Healthcare-Focused Venture Funds Announce Strategic Growth Investment of up to $430 Million in Saama

Life Sciences Times - 0
Venture Capital

D&D Pharmatech Raises $51M in Series C Financing to Advance Potential Disease-Modifying Treatments for Neurodegenerative, Fibrotic, and Metabolic Diseases

Life Sciences Times - 0
Venture Capital

Sofinnova Partners Raises €472 ($548) Million to Form Largest Early-Stage Healthcare VC Fund in Europe

Life Sciences Times - 0
Venture Capital

Aditxt Announces Pricing of $4.25 Million Public Offering

Life Sciences Times - 0
Venture Capital

Sanaby Health Acquisition Corp. I Announces Pricing of $150 Million Initial Public Offering

Life Sciences Times - 0
Venture Capital

Culture Biosciences Raises $80M Series B to Tackle Demand for Large-Scale Biomanufacturing

Life Sciences Times - 0
Venture Capital

Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million

Life Sciences Times - 0
1...939495...112Page 94 of 112

Most Read